Year |
Citation |
Score |
2014 |
Vrshek-Schallhorn S, Wolitzky-Taylor K, Doane LD, Epstein A, Sumner JA, Mineka S, Zinbarg RE, Craske MG, Isaia A, Hammen C, Adam EK. Validating new summary indices for the Childhood Trauma Interview: associations with first onsets of major depressive disorder and anxiety disorders. Psychological Assessment. 26: 730-40. PMID 24819409 DOI: 10.1037/A0036842 |
0.314 |
|
2012 |
Uliaszek AA, Zinbarg RE, Mineka S, Craske MG, Griffith JW, Sutton JM, Epstein A, Hammen C. A longitudinal examination of stress generation in depressive and anxiety disorders. Journal of Abnormal Psychology. 121: 4-15. PMID 22004114 DOI: 10.1037/A0025835 |
0.334 |
|
2012 |
Craske MG, Wolitzky-Taylor KB, Mineka S, Zinbarg R, Waters AM, Vrshek-Schallhorn S, Epstein A, Naliboff B, Ornitz E. Elevated responding to safe conditions as a specific risk factor for anxiety versus depressive disorders: evidence from a longitudinal investigation. Journal of Abnormal Psychology. 121: 315-24. PMID 21988452 DOI: 10.1037/A0025738 |
0.328 |
|
2010 |
Lewis AR, Zinbarg RE, Mineka S, Craske MG, Epstein A, Griffith JW. The relationship between anxiety sensitivity and latent symptoms of emotional problems: A structural equation modeling approach. Behaviour Research and Therapy. 48: 761-9. PMID 20510917 DOI: 10.1016/J.Brat.2010.05.001 |
0.317 |
|
2010 |
Prenoveau JM, Zinbarg RE, Craske MG, Mineka S, Griffith JW, Epstein AM. Testing a hierarchical model of anxiety and depression in adolescents: a tri-level model. Journal of Anxiety Disorders. 24: 334-44. PMID 20171054 DOI: 10.1016/J.Janxdis.2010.01.006 |
0.421 |
|
2010 |
Roche DJ, Childs E, Epstein AM, King AC. Acute HPA axis response to naltrexone differs in female vs. male smokers. Psychoneuroendocrinology. 35: 596-606. PMID 19837518 DOI: 10.1016/J.Psyneuen.2009.09.016 |
0.425 |
|
2009 |
Kircanski K, Craske MG, Epstein AM, Wittchen HU. Subtypes of panic attacks: a critical review of the empirical literature. Depression and Anxiety. 26: 878-87. PMID 19750553 DOI: 10.1002/Da.20603 |
0.306 |
|
2009 |
King A, Epstein A, Conrad M, McNamara P, Cao D. Sex differences in the relationship between alcohol-associated smoking urge and behavior: a pilot study. The American Journal On Addictions. 17: 347-53. PMID 18770076 DOI: 10.1080/10550490802268140 |
0.499 |
|
2008 |
Walsh Z, Epstein A, Munisamy G, King A. The impact of depressive symptoms on the efficacy of naltrexone in smoking cessation. Journal of Addictive Diseases. 27: 65-72. PMID 18551889 DOI: 10.1300/J069V27N01_07 |
0.425 |
|
2007 |
Epstein AM, Sher TG, Young MA, King AC. Tobacco chippers show robust increases in smoking urge after alcohol consumption. Psychopharmacology. 190: 321-9. PMID 16804691 DOI: 10.1007/S00213-006-0438-8 |
0.645 |
|
2005 |
King AC, Epstein AM. Alcohol dose-dependent increases in smoking urge in light smokers. Alcoholism, Clinical and Experimental Research. 29: 547-52. PMID 15834219 DOI: 10.1097/01.Alc.0000158839.65251.Fe |
0.51 |
|
2004 |
Epstein AM, King AC. Naltrexone attenuates acute cigarette smoking behavior. Pharmacology, Biochemistry, and Behavior. 77: 29-37. PMID 14724039 DOI: 10.1016/J.Pbb.2003.09.017 |
0.553 |
|
2000 |
Cutler DM, Epstein AM, Frank RG, Hartman R, King C, Newhouse JP, Rosenthal MB, Vigdor ER. How Good a Deal Was the Tobacco Settlement?: Assessing Payments to Massachusetts Journal of Risk and Uncertainty. 21: 235-261. DOI: 10.1023/A:1007863408004 |
0.302 |
|
Show low-probability matches. |